Kidney outcomes with SGLT2is for type 2 diabetes patients: does background treatment with metformin or RASis matter?

IntroductionThere is a lack of real-world evidence regarding the impact of concomitant metformin and renin-angiotensin system inhibitors (RASis) on sodium-glucose cotransporter-2 inhibitor (SGLT2i)-associated kidney outcomes. This study was aimed to investigate whether SGLT2i-associated kidney outco...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Kah Suan Chong, Yi-Hsin Chang, Meng-Hsuan Lin, Chien-Ning Hsu, Chi-Chuan Wang, Chih-Yuan Wang, Yun-Lin Huang, Fang-Ju Lin, Huang-Tz Ou
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2024-06-01
Serier:	Frontiers in Endocrinology
Fag:	sodium-glucose cotransporter-2 inhibitors metformin renin-angiotensin system inhibitors estimated glomerular filtration rate kidney function
Online adgang:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1329945/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!